CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale Chief Executive Officer sold 39,732 shares at an average $185.90 ($7,385,983)
- 4 Open-market sale Director sold 11,000 shares at an average $184.09 ($2,024,971)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CMO, Hematology acquired 48,438 shares (grant or award)
- 4 Grant or award CFO & Chief Strategy Officer acquired 55,887 shares (grant or award)
- 4 Grant or award President & GM China acquired 134,147 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 900 shares at $175.07 ($157,563)
- 4 Open-market sale CFO & Chief Strategy Officer sold 453 shares at $170.84 ($77,391)
- 4 Open-market sale President & GM China sold 2,800 shares at an average $170.83 ($478,317)
- 4 Open-market sale CMO, Hematology sold 631 shares at $170.84 ($107,800)
- 4 Open-market sale Director sold 6,000 shares at an average $170.91 ($1,025,455)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $163.86 ($245,784)
Page 20 of 29 · 580 filings